ST

Swati Tandon

Active Director Director DIN 09481789
DIN 09481789 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Swati Tandon

Data last updated:

Swati Tandon is a Director at Endoglands And Health Forum (since 2022) and Director at Ceeds Healthtech Private Limited (since 2022). The companies operate in Healthcare.

DIN 09481789
Primary Designation Director
Industry Healthcare
First Appointment 27 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Endoglands And Health Forum U85190DL2022NPL394587
Director03 Mar 20222022Active
Ceeds Healthtech Private Limited U85110DL2022PTC392929
Director27 Jan 20222022Active

Board colleagues of Swati Tandon

Directorship timeline

Open interactive timeline →
Ceeds Healthtech Private Limited
Endoglands And Health Forum
Premium access

Shareholding and investment profile for Swati Tandon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Tandon

Swati Tandon currently holds 2 directorships: Endoglands And Health Forum (Director, since 03 Mar 2022); Ceeds Healthtech Private Limited (Director, since 27 Jan 2022).

Swati Tandon was first appointed on 27 Jan 2022 as Director at Ceeds Healthtech Private Limited.

The current boards of Swati Tandon's companies include Arun Kumar Chandresh Singh (Endoglands And Health Forum).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available